Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma

Current state of immunotherapy for glioblastoma

(2018) Michael Lim et al.   Nature Reviews Clinical Oncology

Multidimensional communication in the microenvirons of glioblastoma

(2018) Marike L. Broekman et al.   Nature Reviews Neurology

An Experimenter’s Guide to Glioblastoma Invasion Pathways

(2018) Mark C. de Gooijer et al.   TRENDS IN MOLECULAR MEDICINE

Overcoming therapeutic resistance in glioblastoma: the way forward

(2017) Satoru Osuka et al.   JOURNAL OF CLINICAL INVESTIGATION

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

(2017) Martin J van den Bent et al.   LANCET

Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma

(2017) Wilson X Mai et al.   NATURE MEDICINE

Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells

(2017) Hui K. Gan et al.   Nature Reviews Clinical Oncology

G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes

(2017) Li Yin et al.   Oncotarget

SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer

(2016) Qunwei Wang et al.   CANCER INVESTIGATION

TP53 and Histone H3.3 Mutations in Triple-Negative Lower-Grade Gliomas

(2016) Aden K. Chan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme

(2015) Bruno Kovic et al.   JOURNAL OF CLINICAL ONCOLOGY

Small extracellular vesicles as tumor biomarkers for glioblastoma

(2015) Keon Mahmoudi et al.   MOLECULAR ASPECTS OF MEDICINE

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

(2015) Duane A. Mitchell et al.   NATURE

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glioblastoma multiforme: Pathogenesis and treatment

(2015) Constantinos Alifieris et al.   PHARMACOLOGY & THERAPEUTICS

The membrane remodeling protein Pex11p activates the GTPase Dnm1p during peroxisomal fission

(2015) Chris Williams et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Engineering strategies to mimic the glioblastoma microenvironment

(2014) Andrew Rape et al.   ADVANCED DRUG DELIVERY REVIEWS

Emerging treatment strategies for glioblastoma multiforme

(2014) S. K. Carlsson et al.   EMBO Molecular Medicine

CFIm25 links alternative polyadenylation to glioblastoma tumour suppression

(2014) Chioniso P. Masamha et al.   NATURE

Glioblastoma and Other Malignant Gliomas

(2013) Antonio Omuro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Emerging insights into the molecular and cellular basis of glioblastoma

(2012) G. P. Dunn et al.   GENES & DEVELOPMENT

The disturbed blood–brain barrier in human glioblastoma

(2012) Hartwig Wolburg et al.   MOLECULAR ASPECTS OF MEDICINE